Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants

• Egile Nagusiak: Daijiro Takahashi (Egilea), Tomohiko Nakamura (Egilea), Reiko Shigematsu (Egilea), Miyu Matsui (Egilea), Shunsuke Araki (Egilea), Kazuyasu Kubo (Egilea), Hiroshi Sato (Egilea), Akira Shirahata (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2009-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

We conducted a retrospective case series study to evaluate the safety of fosfluconazole prophylaxis for preventing invasive fungal infection in VLBW infants with a central vascular access. Fosfluconazole was administered intravenously at a dose of 6 mg/kg everyday during which time a central venous...